Broadleaf Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Buy |
6,018
+22
| +0.4% | +$9.79K | 0.59% | 44 |
|
|
2025
Q1 | $2.91M | Sell |
5,996
-10,927
| -65% | -$5.3M | 0.76% | 42 |
|
|
2024
Q4 | $6.81M | Sell |
16,923
-201
| -1% | -$80.9K | 1.59% | 25 |
|
|
2024
Q3 | $7.96M | Sell |
17,124
-84
| -0.5% | -$39.1K | 1.88% | 22 |
|
|
2024
Q2 | $8.07M | Sell |
17,208
-114
| -0.7% | -$53.4K | 1.95% | 21 |
|
|
2024
Q1 | $7.24M | Sell |
17,322
-81
| -0.5% | -$33.9K | 1.86% | 21 |
|
|
2023
Q4 | $7.08M | Sell |
17,403
-62
| -0.4% | -$25.2K | 2.08% | 18 |
|
|
2023
Q3 | $6.07M | Sell |
17,465
-133
| -0.8% | -$46.2K | 2.03% | 25 |
|
|
2023
Q2 | $6.19M | Buy |
+17,598
| New | +$6.19M | 2.02% | 27 |
|
|
2021
Q4 | – | Sell |
-38,424
| Closed | -$6.97M | – | 76 |
|
|
2021
Q3 | $6.97M | Buy |
38,424
+1,595
| +4% | +$289K | 2.31% | 18 |
|
|
2021
Q2 | $7.43M | Buy |
36,829
+4,510
| +14% | +$909K | 2.58% | 10 |
|
|
2021
Q1 | $6.95M | Buy |
32,319
+1,434
| +5% | +$308K | 2.62% | 11 |
|
|
2020
Q4 | $7.3M | Buy |
30,885
+62
| +0.2% | +$14.7K | 2.88% | 10 |
|
|
2020
Q3 | $8.39M | Buy |
30,823
+4,925
| +19% | +$1.34M | 3.7% | 6 |
|
|
2020
Q2 | $7.52M | Sell |
25,898
-3,079
| -11% | -$894K | 3.68% | 8 |
|
|
2020
Q1 | $6.9M | Sell |
28,977
-198
| -0.7% | -$47.1K | 4.44% | 5 |
|
|
2019
Q4 | $6.39M | Sell |
29,175
-157
| -0.5% | -$34.4K | 3.5% | 8 |
|
|
2019
Q3 | $4.97M | Buy |
29,332
+6,104
| +26% | +$1.03M | 3.11% | 8 |
|
|
2019
Q2 | $4.26M | Buy |
23,228
+487
| +2% | +$89.3K | 2.73% | 13 |
|
|
2019
Q1 | $4.18M | Buy |
22,741
+1,009
| +5% | +$186K | 2.92% | 11 |
|
|
2018
Q4 | $3.6M | Buy |
21,732
+2,609
| +14% | +$432K | 2.88% | 11 |
|
|
2018
Q3 | $3.69M | Sell |
19,123
-246
| -1% | -$47.4K | 2.47% | 13 |
|
|
2018
Q2 | $3.29M | Buy |
+19,369
| New | +$3.29M | 2.41% | 17 |
|